EUVIMEDEUVIMED entdecken
Crossref

Quality of life and somatic physical function of patients with colorectal cancer who underwent oxaliplatin-based systemic chemotherapy: a prospective study

Alper Tuğral, Eyüp Kebabcı, Zeynep Arıbaş, Murat Akyol, Ayşegül Can, Yeşim Bakar

Supportive Care in Cancer · 2024

DOI: 10.1007/s00520-024-08937-x ↗

Kurz gefasst

Fachartikel in der Zeitschrift Supportive Care in Cancer, 2024. Verfasst von Alper Tuğral und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physiotherapy and Rehabilitation, Faculty of Health Sciences, Izmir Bakırçay University, Izmir, Turkey. alper.tugral@bakircay.edu.tr. Hauptthemen laut MEDLINE: Quality of Life, Colorectal Neoplasms, Oxaliplatin, Hand Strength. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 44 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION: This study aimed to study the potential effects of oxaliplatin-based chemotherapy on cardiorespiratory fitness, handgrip strength (HGS), body composition, and quality of life (QoL) of stages III-IV colorectal cancer (CRC) patients before the first cycle (T0) and after the last cycle of systemic adjuvant/neoadjuvant chemotherapy (T1). METHODS: Cardiorespiratory fitness, HGS, body composition, and QoL were evaluated with the six-minute walk test (6MWT), hydraulic hand dynamometer, body composition analyzer, and Functional Assessment of Cancer Therapy-Colon (FACT-C) questionnaire in both T0 and T1, respectively. RESULTS: Twenty-eight CRC patients were included in this study. The total walked distance (TWD) was found to be decreased from T0 to T1 (499.72 m vs. 488.56 m); however, this change was not significant (z = -.706, p = 0.48). Type of chemotherapy whether adjuvant or neoadjuvant also showed no significant effect on TWD (z = -.1.372, p = .17 vs z = -1.180, p = .238, respectively). The QoL was significantly decreased (T0 = 118.35 vs T1 = 110.77, t = 2.176,p = 0.05). The TWD was significantly correlated with the physical well-being (PWB) subscale of FACT-C (r = .64, p = 0.001) as well as with HGS (r = .46, p = .018) in T0. After controlling for age, type of chemotherapy, and type of regimen, the HGS did not show a significant difference from T0 to T1 (F(1,23) = 1.557, p = .22, ηp2 = .06). However, the effect of time x gender showed significant difference from T0 to T1 (F(1,23) = 4.906, p = .037, ηp2 = .17). CONCLUSION: This study showed the decreased QoL and physical well-being of CRC patients who underwent oxaliplatin-based treatment. In addition, the gender effect of decreased HGS should be considered further when planning an oncological rehabilitation program.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Quality of LifeColorectal NeoplasmsOxaliplatinHand StrengthHumansMaleFemaleProspective StudiesMiddle AgedAgedCardiorespiratory FitnessChemotherapy, AdjuvantBody CompositionSurveys and QuestionnairesNeoadjuvant TherapyAntineoplastic Combined Chemotherapy ProtocolsAntineoplastic AgentsAdult

Stichwörter der Autor:innen

Cardiorespiratory fitnessChemotherapyColorectal cancerSix-minute walk test

Substanzen

OxaliplatinAntineoplastic Agents

Autor:innen und Institutionen

  • Department of Physiotherapy and Rehabilitation, Faculty of Health Sciences, Izmir Bakırçay University, Izmir, Turkey. alper.tugral@bakircay.edu.tr.
  • Department of General Surgery, Faculty of Medicine, Izmir Bakırçay University, Izmir, Turkey.
  • Department of Physiotherapy and Rehabilitation, Faculty of Health Sciences, Trakya University, Edirne, Turkey.
  • Department of Medical Oncology, Faculty of Medicine, Izmir Bakırçay University, Izmir, Turkey.
  • Department of Internal Medicine, Faculty of Medicine, Izmir Bakırçay University, Izmir, Turkey.
  • Department of Physiotherapy and Rehabilitation, Faculty of Health Sciences, Izmir Bakırçay University, Izmir, Turkey.

Zitieren

APA

Tuğral, A., Kebabcı, E., Arıbaş, Z., Akyol, M., Can, A., & Bakar, Y. (2024). Quality of life and somatic physical function of patients with colorectal cancer who underwent oxaliplatin-based systemic chemotherapy: a prospective study. Supportive Care in Cancer. https://doi.org/10.1007/s00520-024-08937-x

Vancouver

Tuğral A, Kebabcı E, Arıbaş Z, Akyol M, Can A, Bakar Y. Quality of life and somatic physical function of patients with colorectal cancer who underwent oxaliplatin-based systemic chemotherapy: a prospective study. Supportive Care in Cancer. 2024. doi:10.1007/s00520-024-08937-x

BibTeX
@article{Tural2024,
  author = {Tuğral, Alper and Kebabcı, Eyüp and Arıbaş, Zeynep and Akyol, Murat and Can, Ayşegül and Bakar, Yeşim},
  title = {Quality of life and somatic physical function of patients with colorectal cancer who underwent oxaliplatin-based systemic chemotherapy: a prospective study},
  journal = {Supportive Care in Cancer},
  year = {2024},
  doi = {10.1007/s00520-024-08937-x}
}
Kostenlos starten →